Home > ESG > Governance > Investigator Initiated Studies (IIS)

Introduction

At Britannia we provide cutting-edge therapies that improve patient outcomes globally. We recognise the importance of pioneering clinical research to explore critical medical and scientific questions within our therapeutic focus areas. Our commitment to innovation drives us to deliver solutions that truly make a difference in patients’ lives.

smiling-woman-with-shaved-head

How We Utilise Research for Our Therapies

At Britannia, we believe that collaboration with the scientific community is essential for advancing healthcare solutions. An Independent Investigator Studies (IIS) is an unsolicited request for funding and/or support (such as drug products) from external investigators who wish to conduct independent scientific studies. IISs are thoughtfully conceived and managed by qualified investigators – those not affiliated with BPL. These professionals possess the necessary scientific expertise and experience to design, initiate, conduct, analyse, and report their investigations. Through IISs, we aim to foster innovative research that contributes valuable findings to our therapeutic areas of interest. To explore our specific therapeutic focuses, please visit our Therapies section.

Areas of Research Interest
close-up-of-pipette

Eligibility for IIS Support

Only institutions and organizations are eligible to receive IIS support from BPL – individuals are not eligible.
Healthcare Professionals (HCPs) acting as primary investigators or co-investigators, along with their affiliated institutions, will undergo a thorough screening process to determine eligibility.

Apply to participate

Make an Application

If you’re an investigator, you can apply by using the button below.

Download Application Form Submit Application Form

Job Code: UK--2500023 | Date of Preparation: December 2025